IGFBP3 and neoplasm: However, between different Ewing sarcoma subtypes, only patients with high-grade tumor (3.93 ± 0.13) expressed a significant elevated level of IGFBP-3 compared to patients with low-grade tumor (3.24 ± 0.17) (P=0.005) (Figure 6E).